Mechanisms of Chromium Action: Low-Molecular-Weight Chromium-Binding Substance

Journal of the American College of Nutrition

Volumn 18, Issue 1, 1999, Pages 6-12

  Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

Chromium; Insulin receptor; Kinase; Low molecular weight chromium binding substance

Indexed keywords

CALCIUM BINDING PROTEIN; CALMODULIN; CHROMIUM; INSULIN RECEPTOR; OLIGOPEPTIDE; TYROSINE KINASE RECEPTOR;

CALCIUM BINDING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GLUCOSE TOLERANCE; HORMONE RECEPTOR INTERACTION; HUMAN; LIPID METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; REVIEW;

ANIMALS; CHROMIUM; HUMANS; MOLECULAR WEIGHT; OLIGOPEPTIDES; RECEPTOR, INSULIN;

EID: 0033024516     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1999.10718821     Document Type: Article

References (55)

1. Frausto da Silva JR, Williams RJP Jr: “Biological Chemistry of the Elements.” Oxford: Oxford University Press, 1991.
2. Lippard SJ, Berg JM: “Principles of Bioinorganic Chemistry.” Mill Valley: University Science Books, 1994.
3. Kaim W, Schwederski B: “Bioinorganic Chemistry.” Chichester: Wiley, 1994.
4. Holm RH, Kennepohl P, Solomon EI: Structural and functional aspects of metal sites in biology. Chem Rev 96: 2239-2314, 1996.
5. Schwartz K, Mertz W: A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys 72: 515-518, 1957.
6. Schwartz K, Mertz W: Chromium(III) and glucose tolerance factor. Arch Biochem Biophys 85: 292-295, 1959.
7. Mertz W, Roginski EE, Schwartz K: Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats. J Biol Chem 236: 318-322, 1961.
8. Toepfer EW, Mertz W, Polansky MM, Roginski EE, Wolfe WR: Preparation of chromium-containing material of glucose tolerance factor activity from Brewer's yeast extracts and by synthesis. J Agricul Food Chem 25: 162-166, 1977.
9. Anderson RA, Brantner JH, Polansky MM: An improved assay for biologically active chromium. J Agricul Food Chem 26: 1219-1221, 1978.
10. Gonzalez-Vergara E, Hegenauer J, Saltman P: Biological complexes of chromium: a second look at glucose tolerance factor. Fed Proc 41: 286, 1982.
11. Haylock SJ, Buckley PD, Blackwell LF: Separation of biologically active chromium-containing complexes from yeast extracts and other sources of glucose tolerance factor (GTF) activity. J Inorg Biochem 18: 195-211, 1983.
12. Kumpulainen J, Koivistoinen P, Lahtinen S: Isolation, purification, and partial characterization of chromium(III) fractions existing in Brewer's yeast and Sabourand's liquid medium. Bioinorg Chem 8: 419-429, 1978.
13. Barrett J, O'Brien P: Chromium(III) and the glucose tolerance factor. Polyhedron 4: 1-14, 1985.
14. Evans GW, Bowman TD: Chromium picolinate increases membrane fluidity and rate of insulin internalization. J Inorg Biochem 46: 243-250, 1992.
15. McCarty MF: Hypothesis: sensitization of insulin-dependent hypothalamic glucoreceptors may account for the fat-reducing effects of chromium picolinate. J Opt Nutr 2: 36-53, 1993.
16. Vincent JB: Relationship between glucose tolerance factor and low-molecular-weight chromium-binding substance. J Nutr 124: 117-118, 1994.
17. Vincent JB: Chromium: biological relevance. In: King B (ed): “Encyclopedia of Inorganic Chemistry,” vol. 2. New York: Wiley, pp 661-665, 1994.
18. Stearns DM, Wise JP Sr, Patierno SR, Wetterhahn KE: Chromium picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 9: 1643-1648, 1995.
19. Stearns DM, Belbruno JJ, Weterhahn KE: A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J 9: 1650-1657, 1995.
20. Anderson RA, Bryden NA, Polansky MM: Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 16: 273-279, 1997.
21. Anderson RA: Chromium supplementation: effects on glucose tolerance and lipid metabolism. In: “Trace Elements in Health and Disease.” Stockholm: Norstedt, pp 110-124, 1985.
22. Anderson RA: Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem 4: 31-41, 1986.
23. Anderson RA: Chromium. In: Mertz W (ed): “Trace Elements in Human and Animal Nutrition,” vol 1. Orlando: Academic Press, pp 225-244, 1987.
24. Anderson RA: Chromium, glucose tolerance and diabetes. Biol Trace Elem Res 32: 19-24, 1992.
25. Anderson RA: Essentiality of chromium in humans. Sci Total Environ 86: 75-81, 1989.
26. Anderson RA: Chromium and parenteral nutrition. Nutrition 11: 83-86, 1995.
27. Mertz W: Chromium in human nutrition: a review. J Nutr 123: 626-633, 1993.
28. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46: 1786-1791, 1997.
29. Ravina A, Slezack L: Chromium in the treatment of clinical diabetes mellitus. Harefuah 125: 142-145, 1993.
30. Yamamoto A, Wada O, Ono T: Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver. Eur J Biochem 165: 627-631, 1987.
31. Yamamoto A, Wada O, Manabe S: Evidence that chromium is an essential factor for biological activity of low-molecular-weight chromium-binding substance. Biochem Biophys Res Commun 163: 189-193, 1989.
32. Yamamoto A, Wada O, Suzuki H: Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr 118: 39-45, 1988.
33. Wada O, Wu GY, Yamamoto A, Manabe S, Ono T: Purification and chromium-excretory function of low-molecular-weight, chromium-binding substances from dog liver. Environ Res 32: 228-239, 1983.
34. Yamamoto A, Wada O, Ono T: Distribution and chromiumbinding capacity of a low-molecular-weight, chromium-binding substance in mice. J Inorg Biochem 22: 91-102, 1984.
35. Davis CM, Vincent JB: Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36: 4382-4385, 1997.
36. Davis CM, Sumrall KH, Vincent JB: The biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35: 12963-12969, 1996.
37. Davis CM, Vincent JB: Chromium in carbohydrate and lipid metabolism. J Biol Inorg Chem 2: 675-679, 1997.
38. Sumrall KH, Vincent JB: Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromiumbinding substance? Polyhedron 16: 4171-4177, 1997.
39. Davis CM, Vincent JB: The biologically active form of chromium contains a multinuclear chromium(III) assembly. Arch Biochem Biophys 339: 335-343, 1997.
40. Davis CM, Royer AC, Vincent JB: Synthetic multinuclear chromium assembly activates insulin receptor kinase activity: functional model for low-molecular-weight chromium-binding substance. Inorg Chem 36: 5316-5320, 1997.
41. Glass MM, Belmore K, Vincent JB: Nuclear magnetic resonance studies of multinuclear chromium assemblies. Polyhedron 12: 133-140, 1993.
42. Vincent JB: Heteronuclear carboxylates of chromium(III) and iron(III): mixtures or pure compounds. Inorg Chem 33, 5604-5606, 1994.
43. Belmore K, Madison XJ, Harton A, Vincent JB: C-13 NMR studies of oxo-centered trinuclear Cr(III) complexes of the general formula [Cr3O(O2CR)6(L)3]1 (R5Me, Ph; L5H2O, py). Spectrochim Acta 50A: 2365-2370, 1994.
44. Ellis T, Glass M, Harton A, Huffman JC, Vincent JB: Synthetic models for low-molecular-weight chromium-binding substance: synthesis and characterization of oxo-bridged tetranuclear chromium(III) assemblies. Inorg Chem 33: 5522-5527, 1994.
45. Yoshimoto S, Sakamoto K, Wakabayashi I, Masui H: Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. Metabolism 41: 636-642, 1992.
46. Heldin C-H: Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223, 1995.
47. Morris BW, Gray TA, MacNeil S: Glucose-dependent uptake of chromium in human and rat insulin-sensitive tissues. Clin Chem 84: 447-452, 1993.
48. Morris BW, MacNeil S, Stanley K, Gray TA, Fraser R: The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrin 139: 339-345, 1993.
49. Morris BW, Blumsohn A, MacNeil S, Gray TA: The trace element chromium-a role in glucose homeostasis. Am J Clin Nutr 55: 989-991, 1992.
50. Babu YS, Bugg CE, Cook WJ: Structure of calmodulin at 2.2 Å resolution. J Mol Biol 204: 191-204, 1988.
51. Meador WE, Means AR, Quiocho FA: Target enzyme recognition by calmodulin: 2.4 Å structure of a calmodulin-peptide complex. Science 257: 1251-1255, 1992.
52. Martinez OB, MacDonald AC, Gibson RS, Bourn O: Dietary chromium and effect of chromium supplementation on glucose tolerance of elderly Canadian women. Nutr Res 5: 609-620, 1985.
53. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY, Reamer DC: Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes 31: 212-216, 1982.
54. Anderson RA, Bryden NA, Polansky, Reiser S: Urinary chromium excretion and insulinogenic properties of carbohydrates. Am J Clin Nutr 51: 864-868, 1990.
55. Mertz W, Roginski EE: “Chromium metabolism: the glucose tolerance factor.” In: Mertz W, Cornatzer WE (eds) “Newer Trace Elements in Nutrition.” New York: Marcel Dekker, pp 123-153, 1971.